Abeona Therapeutics Inc vs TeraWulf Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while TeraWulf Inc trades at $17.41 (market cap $8.35B). The key difference: TeraWulf Inc is far larger — about 19.8× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, TeraWulf Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | WULF | |
|---|---|---|
Market Cap | $421.19M | $8.35B |
Sector | Health | Technology |
52-Week High | $7.45 | $28.98 |
52-Week Low | $4.17 | $5.24 |
Enterprise Value | $276.10M | $10.97B |
Trailing returns across standard periods
Latest headlines on both assets
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →TeraWulf develops, owns, and operates fully integrated digital infrastructure powered by predominantly zero-carbon energy. It utilizes a hybrid business model that combines industrial-scale Bitcoin mining with high-performance computing (HPC) and AI hosting, leveraging sustainable power sources like nuclear and hydroelectric to deliver low-cost, energy-efficient data center solutions.
Read more on WULF →